Wound Debridement in Hermansky-Pudlak Syndrome
Yes, you can debride the wound in a patient with Hermansky-Pudlak syndrome (HPS), but only with mandatory hemostatic prophylaxis including DDAVP, HLA-matched platelet transfusions, and local hemostatic agents.
Understanding the Bleeding Risk
HPS is characterized by a platelet storage pool defect causing significant bleeding diathesis, even when routine platelet counts and bleeding times appear normal 1, 2. The syndrome involves defective lysosome-related organelle biogenesis affecting platelet dense granules, making these patients high-risk for any invasive procedure including wound debridement 3.
Required Hemostatic Protocol
Based on successful surgical outcomes in HPS patients, the following algorithm should be implemented:
Preoperative Preparation
- Reserve HLA-matched apheresis platelets before the procedure 1
- Administer DDAVP (1-deamino-8-d-arginine vasopressin) intravenously 2 hours before debridement 1, 4
- Consider tranexamic acid as an adjunctive antifibrinolytic agent 4
Intraoperative Management
- Transfuse HLA-matched platelets during the procedure (typically 1 unit) 1
- Apply local hemostatic agents directly to the debrided wound bed:
- Avitene (microfibrillar collagen)
- Gelfoam (absorbable gelatin sponge)
- Pack these materials into the wound site 1
Postoperative Vigilance
- Monitor for delayed bleeding for at least 72 hours, as wound hematomas and secondary bleeding can occur even with appropriate prophylaxis 5
- Maintain platelet transfusion schedule if extensive debridement was performed 5
Critical Pitfalls to Avoid
Do not rely on normal bleeding time or platelet count to assess bleeding risk—these tests do not predict bleeding in HPS due to the qualitative platelet defect 1, 2. The bleeding tendency in HPS stems from abnormal platelet aggregation and adenosine diphosphate deficiency, not platelet number 2.
Do not proceed without secured platelet availability—continuous oozing from surgical sites is characteristic even with minor procedures 6. One case of video-assisted surgery resulted in 270 mL blood loss, which was considered excessive for that procedure type 6.
Evidence Strength
The recommendation is based on multiple successful case reports demonstrating safe invasive procedures in HPS patients when appropriate hemostatic measures are employed 1, 5, 2, 4. While no specific guidelines exist for wound debridement in HPS, the consistent success across tooth extractions, cesarean sections, and major orthopedic surgeries using this hemostatic protocol provides strong support for this approach 1, 5, 4.
The key principle: wound debridement is feasible and safe in HPS, but never without comprehensive hemostatic prophylaxis—this is non-negotiable for patient safety.